Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403441 · ClinicalTrials.gov registry record · NA
Radiosurgical Neuromodulation for Refractory Depression
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01403441: Clinical Trial NA study, sponsored by Stanford University.
NCT01403441 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01403441, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and effectiveness of an investigational procedure for treating people with treatment resistant bipolar depression (TRD). Precise dose delivery of radiation to the predetermined targets in the brain will be accomplished with known Cyberknife stereotactic radiosurgery methods. This technology is considered to be noninvasive (does not physically invade your body). We will be studying if the Cyberknife influences the sensitivity of certain nerves of your brain. Although many clinical treatments for psychiatric conditions have been done using stereotactic radiosurgery, the present study is experimental, because we are seeking to use more moderate doses of radiation that are intended not to destroy any brain cells, but to normalize or modulate their function.
Interventions
- DEVICE Radiosurgical Neuromodulation using the Cyberknife
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01403441
The ClinicalTrials.gov registry entry for NCT01403441 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiosurgical Neuromodulation using the Cyberknife is the first listed.
NCT01403441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01403441 about?
NCT01403441 is a clinical study titled "Radiosurgical Neuromodulation for Refractory Depression". This study is designed to evaluate the safety and effectiveness of an investigational procedure for treating people with treatment resistant bipolar depression (TRD). Precise dose delivery of radiation to the predetermined targets in the brain will be accomplished with known Cyberknife stereotactic ...
What is the current status of trial NCT01403441?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2010-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01403441?
The interventions under investigation include: Radiosurgical Neuromodulation using the Cyberknife (DEVICE).
Who is sponsoring clinical trial NCT01403441?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.